Abstract
Objective: Advanced/recurrent gynecologic malignancies are a heterogeneous group of cancers with limited treatment options lacking predictive biomarkers. The personalized oncogenomics program (POG) is a British Columbia cancer investigational program that performs whole genome and transcriptome sequencing (WGTS) of recurrent cancers. A tumor board identifies potentially predictive and actionable biomarkers. We analyzed the discussed actionable items and their impact on treatment decisions among patients with recurrent gynecologic cancers.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.